**Exhibit99.1**

** **

Angeion Corporation

350 Oak Grove Parkway

St. Paul, MN 55127 USA

Telephone: (651) 484-4874

Facsimile:  (651) 484-4826

 

 

**FOR IMMEDIATE RELEASE**
| Contact: | Richard Jahnke,  President and CEO, (651) 484-4874  |
|----------|-----------------------------------------------------|
|     | Bill Bartkowski,  Bluefire Partners, (612) 344-1012 |

 

 

**AngeionCorporation CEO to Retire at Fiscal Year End**

 

**SAINT PAUL, Minn. (June 9, 2004) —** AngeionCorporation (Nasdaq SC: ANGN) will announce today at its Annual Meeting ofShareholders in Vadnais Heights that Richard E. Jahnke, President and CEO ofAngeion and its Medical Graphics Corporation subsidiary, will retire at the endof the fiscal year on October 31, 2004. Jahnke, 55, became the CEO of Medical Graphics in August 1998 and alsobecame CEO of Angeion in January 2000 after Angeion acquired Medical Graphicsin December 1999.

 

The Board of Directorsbegan the search for a replacement several months ago and has selected RodneyA. Young to succeed Jahnke.  Young, 49,is a 25-year veteran of the medical services field and was most recentlyPresident and CEO of LecTec Corporation. Prior to joining LecTec in 1996, Young was Vice President of specializeddistribution at Baxter International and previously held a variety of sales andmarketing positions at 3M Company and Upjohn. He will join the company as Executive Vice President in July and assumethe President and CEO role on November 1, 2004.

 

Jahnke said, “I have anumber of personal interests that I wish to pursue and wanted the time to doso.  The company is well positioned fora leadership change at this time.  Ithas a solid management team, its cardiorespiratory diagnostic products are in agrowth mode with several new products to be released soon, while its New Leafhealth and fitness products are starting to gain traction and momentum.  While I look forward to pursuing my personalinterests, I also intend to stay active in the business community in advisoryroles where my experience can help companies that are in periods of transition,significant change, or growth,” Jahnke concluded.

 

Mr. Young commented, “Iam very pleased to be joining Medical Graphics and I am excited about thebusiness prospects.  Diagnostic productssales are growing and there are additional new products in the pipeline.  I also believe that the New Leaf health andfitness products address a significant emerging market opportunity in thefuture of health care and wellness in America.”

 

Chairman of the BoardArnold A. Angeloni stated, “Rick has provided excellent leadership for MedicalGraphics and Angeion including the successful turnaround of Medical Graphics in1999 and the development of the New Leaf health and fitness products growthinitiative.  The company now has astrong foundation for future growth and the board thanks Rick for his years ofdedicated service and commitment.  Wewish Rick well in his future endeavors and look forward to working with Rod inhis new position.”

 

----

 

- more -

 

Founded in 1986, AngeionCorporation acquired Medical Graphics (www.medgraphics.com) in December 1999.  Medical Graphics develops, manufactures andmarkets non-invasive cardiorespiratory diagnostic systems for the managementand improvement of cardiorespiratory health. The Company has also introduced a line of health and fitness products,many of which are derived from Medical Graphics’ cardiorespiratory producttechnologies.  These products, marketedunder the New Leaf Health and Fitness Brand (www.newleaf-online.com), help consumers effectivelymanage their weight and improve their fitness. They are marketed to the consumer primarily through personal trainingstudios, health and fitness clubs and other exercise facilities.  For more information about Angeion, visitwww.angeion-ir.com.

 

# # #

 

The discussion above contains forward-looking statements within themeaning of the Private Securities Litigation Reform Act of 1995.  These statements by their nature involvesubstantial risks and uncertainties. Actual results may differ materially depending on a variety of factors,including (i) the Company’s ability to successfully operate its MedicalGraphics business including its ability to develop, improve and update itscardiorespiratory diagnostic products, (ii) the Company’s ability tosuccessfully introduce its New Leaf products including its New Leaf Weight LossProgram, (iii) the Company’s ability to successfully defend itself from productliability claims related to its Medical Graphics and New Leaf products orclaims associated with its prior cardiac stimulation products, (iv) theCompany’s ability to protect its intellectual property, (v) the Company’sdependence on third party vendors and (vi) the Company’s ability to comply with Nasdaq listing requirements,including maintenance of the $1.00 per share bid price.  Additional information with respect to therisks and uncertainties faced by the Company may be found in, and the priordiscussion is qualified in its entirety by, the other risk factors that aredescribed from time to time in Angeion’s Securities and Exchange Commissionreports, including but not limited to the Annual Report on Form 10-KSB for theyear ended October 31, 2003, and subsequently filed reports.

 

2

----